US6048729A
(en)
*
|
1987-05-01 |
2000-04-11 |
Transkaryotic Therapies, Inc. |
In vivo protein production and delivery system for gene therapy
|
DE69030660T2
(en)
*
|
1989-03-24 |
1997-09-25 |
Univ California |
ENDOTHELIAL CELL GROWTH FACTOR, INSULATION AND EXPRESSION
|
US6899882B1
(en)
|
1989-03-24 |
2005-05-31 |
The Regents Of The University Of California |
Endothelial cell growth factor methods of isolation and expression
|
US7300791B2
(en)
*
|
1989-05-12 |
2007-11-27 |
Genentech, Inc. |
Production of vascular endothelial cell growth factor and DNA encoding same
|
US5332671A
(en)
*
|
1989-05-12 |
1994-07-26 |
Genetech, Inc. |
Production of vascular endothelial cell growth factor and DNA encoding same
|
US20030114374A1
(en)
*
|
1989-05-12 |
2003-06-19 |
Genentech, Inc. |
Production of vascular endothelial cell growth factor and DNA encoding same
|
DE69024261T2
(en)
*
|
1989-05-24 |
1996-07-18 |
Merck & Co Inc |
Purification and characterization of a growth factor derived from a glioma
|
US5726152A
(en)
*
|
1990-09-21 |
1998-03-10 |
Merck & Co., Inc. |
Vascular endothelial cell growth factor II
|
US6077823A
(en)
*
|
1991-03-11 |
2000-06-20 |
Creative Biomolecules, Inc. |
Method for reducing tissue damage associated with ischemia-reperfusion or hypoxia injury
|
CA2064331C
(en)
*
|
1991-03-28 |
2003-02-18 |
Marvin L. Bayne |
Vascular endothelial cell growth factor c subunit
|
US6582959B2
(en)
|
1991-03-29 |
2003-06-24 |
Genentech, Inc. |
Antibodies to vascular endothelial cell growth factor
|
US5514779A
(en)
*
|
1991-06-07 |
1996-05-07 |
Zeneca Limited |
Biocidal proteins from plants
|
WO1993008210A1
(en)
*
|
1991-10-18 |
1993-04-29 |
Beth Israel Hospital Association |
Vascular permeability factor targeted compounds
|
ATE238417T1
(en)
*
|
1991-11-04 |
2003-05-15 |
Inst Genetics Llc |
RECOMBINANT BONE MORPHOGENETIC PROTEIN HETERODIMERS, COMPOSITIONS AND METHODS OF USE
|
US6054288A
(en)
*
|
1991-11-05 |
2000-04-25 |
Transkaryotic Therapies, Inc. |
In vivo protein production and delivery system for gene therapy
|
US6692737B1
(en)
|
1991-11-05 |
2004-02-17 |
Transkaryotic Therapies, Inc. |
In vivo protein production and delivery system for gene therapy
|
PT101031B
(en)
*
|
1991-11-05 |
2002-07-31 |
Transkaryotic Therapies Inc |
PROCESS FOR THE SUPPLY OF PROTEINS BY GENETIC THERAPY
|
US6063630A
(en)
|
1991-11-05 |
2000-05-16 |
Transkaryotic Therapies, Inc. |
Targeted introduction of DNA into primary or secondary cells and their use for gene therapy
|
US5965132A
(en)
|
1992-03-05 |
1999-10-12 |
Board Of Regents, The University Of Texas System |
Methods and compositions for targeting the vasculature of solid tumors
|
US6749853B1
(en)
|
1992-03-05 |
2004-06-15 |
Board Of Regents, The University Of Texas System |
Combined methods and compositions for coagulation and tumor treatment
|
US6670178B1
(en)
|
1992-07-10 |
2003-12-30 |
Transkaryotic Therapies, Inc. |
In Vivo production and delivery of insulinotropin for gene therapy
|
US6531124B1
(en)
|
1992-07-10 |
2003-03-11 |
Transkaryotic Therapies, Inc. |
In vivo production and delivery of insulinotropin for gene therapy
|
AU5125693A
(en)
*
|
1992-09-03 |
1994-03-29 |
Regents Of The University Of California, The |
Dorsal tissue affecting factor and compositions
|
ATE215565T1
(en)
*
|
1992-10-28 |
2002-04-15 |
Genentech Inc |
USE OF ANTI-VEGF ANTIBODIES TO TREAT CANCER
|
AU6778794A
(en)
*
|
1993-04-29 |
1994-11-21 |
Washington University |
Use of platelet-derived growth factor to improve collateral circulation
|
DE69434053T2
(en)
*
|
1993-06-29 |
2006-02-23 |
Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville |
REDUCED KERATINOCYTE GROWTH FACTOR (KGF) WITH INCREASED BIOLOGICAL ACTIVITY
|
WO1995006131A1
(en)
*
|
1993-08-23 |
1995-03-02 |
Monash University |
A method for the assay, prophylaxis and/or treatment of human disease conditions
|
US5464815A
(en)
*
|
1993-09-08 |
1995-11-07 |
Genentech, Inc. |
Inhibition of heparin-binding
|
CA2179638A1
(en)
*
|
1993-12-24 |
1995-07-06 |
Peter Schulz-Knappe |
Human circulating cytokine cc-1
|
US5480975A
(en)
*
|
1994-02-08 |
1996-01-02 |
Brigham And Women's Hospital |
Induction of vascular endothelial growth factor (VEGF) by transition metals
|
US5840301A
(en)
*
|
1994-02-10 |
1998-11-24 |
Imclone Systems Incorporated |
Methods of use of chimerized, humanized, and single chain antibodies specific to VEGF receptors
|
US5861499A
(en)
*
|
1994-02-10 |
1999-01-19 |
Imclone Systems Incorporated |
Nucleic acid molecules encoding the variable or hypervariable region of a monoclonal antibody that binds to an extracellular domain
|
US6811779B2
(en)
|
1994-02-10 |
2004-11-02 |
Imclone Systems Incorporated |
Methods for reducing tumor growth with VEGF receptor antibody combined with radiation and chemotherapy
|
US6448077B1
(en)
|
1994-02-10 |
2002-09-10 |
Imclone Systems, Inc. |
Chimeric and humanized monoclonal antibodies specific to VEGF receptors
|
US5932540A
(en)
|
1994-03-08 |
1999-08-03 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2
|
US7153827B1
(en)
*
|
1994-03-08 |
2006-12-26 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2 and methods of use
|
US6734285B2
(en)
*
|
1994-03-08 |
2004-05-11 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2 proteins and compositions
|
US6040157A
(en)
*
|
1994-03-08 |
2000-03-21 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2
|
US7186688B1
(en)
|
1994-03-08 |
2007-03-06 |
Human Genome Sciences, Inc. |
Methods of stimulating angiogenesis in a patient by administering vascular endothelial growth factor 2
|
US7109308B1
(en)
|
1994-03-08 |
2006-09-19 |
Human Genome Sciences, Inc. |
Antibodies to human vascular endothelial growth factor 2
|
CA2184584C
(en)
*
|
1994-03-08 |
2003-04-08 |
Jing-Shan Hu |
Vascular endothelial growth factor 2
|
US6608182B1
(en)
*
|
1994-03-08 |
2003-08-19 |
Human Genome Sciences, Inc. |
Human vascular endothelial growth factor 2
|
WO1996000286A1
(en)
*
|
1994-06-27 |
1996-01-04 |
Toagosei Co., Ltd. |
Antisense nucleic acid compound
|
US6152141A
(en)
*
|
1994-07-28 |
2000-11-28 |
Heartport, Inc. |
Method for delivery of therapeutic agents to the heart
|
WO1996006641A1
(en)
*
|
1994-08-29 |
1996-03-07 |
Prizm Pharmaceuticals, Inc. |
Conjugates of vascular endothelial growth factor with targeted agents
|
US6451523B1
(en)
*
|
1994-09-14 |
2002-09-17 |
Interneuron Pharmaceuticals, Inc. |
Detection of a leptin receptor variant and methods for regulating obesity
|
IL114615A0
(en)
*
|
1995-07-16 |
1995-11-27 |
Yeda Res & Dev |
Modulators of the function of fas receptors and other proteins
|
AU720270B2
(en)
*
|
1995-02-09 |
2000-05-25 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Nucleotide and deduced amino acid sequences of tumor gene Int6
|
US6693077B1
(en)
|
1995-02-14 |
2004-02-17 |
Human Genome Sciences, Inc. |
Keratinocyte growth factor-2
|
US7232667B2
(en)
*
|
1995-02-14 |
2007-06-19 |
Human Genome Sciences, Inc. |
Keratinocyte growth factor-2 polynucleotides
|
US6077692A
(en)
*
|
1995-02-14 |
2000-06-20 |
Human Genome Sciences, Inc. |
Keratinocyte growth factor-2
|
US5928939A
(en)
*
|
1995-03-01 |
1999-07-27 |
Ludwig Institute For Cancer Research |
Vascular endothelial growth factor-b and dna coding therefor
|
ES2206558T3
(en)
*
|
1995-03-02 |
2004-05-16 |
Amrad Operations Pty.,Ltd. |
NEW GROWTH FACTOR AND GENETIC SEQUENCE THAT CODIFIES IT.
|
US7160991B1
(en)
*
|
1995-03-02 |
2007-01-09 |
Ludwig Institute For Cancer Research |
Vascular endothelial growth factor polypeptides
|
JPH11503012A
(en)
*
|
1995-03-30 |
1999-03-23 |
ヒューマン ジノーム サイエンシーズ,インコーポレイテッド |
Human G protein-coupled receptor
|
IL117645A
(en)
*
|
1995-03-30 |
2005-08-31 |
Genentech Inc |
Vascular endothelial cell growth factor antagonists for use as medicaments in the treatment of age-related macular degeneration
|
US7429646B1
(en)
*
|
1995-06-05 |
2008-09-30 |
Human Genome Sciences, Inc. |
Antibodies to human tumor necrosis factor receptor-like 2
|
US7427492B1
(en)
*
|
1995-06-05 |
2008-09-23 |
Human Genome Sciences, Inc. |
Polynucleotides encoding human tumor necrosis factor receptor-like2
|
US20020150578A1
(en)
*
|
1995-06-05 |
2002-10-17 |
Human Genome Sciences, Inc. |
Human prostatic specific reductase
|
US20020026037A1
(en)
*
|
1995-06-06 |
2002-02-28 |
Jing-Shan Hu |
Vascular endothelial growth factor 3 antibodies
|
US6013483A
(en)
*
|
1995-06-07 |
2000-01-11 |
Human Genome Sciences, Inc. |
DNA encoding endothelial monocyte activating polypeptide III
|
US7423125B2
(en)
|
1995-08-01 |
2008-09-09 |
Vegenics Limited |
Antibodies to VEGF-C
|
DE69624925T2
(en)
*
|
1995-08-15 |
2003-09-04 |
Connetics Corp |
USE OF RELAXIN TO STIMULATE ANGIOGENESIS
|
EP1382679A3
(en)
|
1995-09-08 |
2004-11-10 |
Genentech, Inc. |
Vascular Endothelial Growth Factor Related Protein (VRP) Antagonists
|
CA2230957A1
(en)
*
|
1995-09-29 |
1997-04-10 |
Universita'degli Studi Di Siena |
Regulated genes and uses thereof
|
US6329169B1
(en)
*
|
1995-09-29 |
2001-12-11 |
Human Genome Sciences, Inc. |
Nucleic acid molecules encoding cytostatin II
|
AU717277B2
(en)
*
|
1995-10-23 |
2000-03-23 |
Children's Medical Center Corporation |
Therapeutic antiangiogenic compositions and methods
|
US7393943B1
(en)
*
|
1995-12-08 |
2008-07-01 |
Human Genome Sciences, Inc. |
Polynucleotides encoding a human chemotactic cytokine I
|
US7888466B2
(en)
*
|
1996-01-11 |
2011-02-15 |
Human Genome Sciences, Inc. |
Human G-protein chemokine receptor HSATU68
|
US7084252B1
(en)
*
|
1996-01-16 |
2006-08-01 |
The Rockefeller University |
DB, the receptor for leptin
|
US7063958B1
(en)
*
|
1996-01-16 |
2006-06-20 |
The Rockefeller University |
Nucleic acids db, the receptor for leptin
|
US20030185792A1
(en)
*
|
1996-01-22 |
2003-10-02 |
Curis, Inc. |
Morphogen analogs of bone morphogenic proteins
|
AU725295B2
(en)
*
|
1996-01-22 |
2000-10-12 |
Brandeis University |
Morphogen analogs and methods for producing them
|
JP3930052B2
(en)
|
1996-02-15 |
2007-06-13 |
バイオセンス・インコーポレイテッド |
Catheter-based surgery
|
US6713061B1
(en)
*
|
1996-03-12 |
2004-03-30 |
Human Genome Sciences, Inc. |
Death domain containing receptors
|
US7357927B2
(en)
*
|
1996-03-12 |
2008-04-15 |
Human Genome Sciences, Inc. |
Death domain containing receptors
|
US6410268B1
(en)
|
1996-03-18 |
2002-06-25 |
Human Genome Sciences, Inc. |
Polynucleotides encoding chemokine alpha-3
|
US6443974B1
(en)
|
1996-07-28 |
2002-09-03 |
Biosense, Inc. |
Electromagnetic cardiac biostimulation
|
DE69739469D1
(en)
*
|
1996-08-23 |
2009-07-30 |
Vegenics Ltd |
Recombinant vascular endothelial growth factor D (VEGF-D)
|
US20030129643A1
(en)
*
|
1996-08-23 |
2003-07-10 |
Human Genome Sciences, Inc. |
T1 receptor-like ligand I
|
AU731647B2
(en)
*
|
1996-08-27 |
2001-04-05 |
Atsunobu Hiraoka |
Hematopoietic stem cell growth factor (SCGF)
|
US6013780A
(en)
*
|
1996-09-06 |
2000-01-11 |
Technion Research & Development Co. Ltd. |
VEGF145 expression vectors
|
US20070299005A1
(en)
*
|
1996-09-24 |
2007-12-27 |
Tanox, Inc. |
Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof
|
EP0928203B1
(en)
|
1996-09-24 |
2006-10-25 |
Merck & Co., Inc. |
Compounds for the inhibition of angiogenesis by gene therapy
|
US20030144202A1
(en)
*
|
1996-10-15 |
2003-07-31 |
Amgen Inc. |
Uses of keratinocyte growth factor-2
|
US6743422B1
(en)
|
1996-10-15 |
2004-06-01 |
Amgen, Inc. |
Keratinocyte growth factor-2 products
|
US6998418B1
(en)
|
1996-11-05 |
2006-02-14 |
Gp Medical, Inc. |
Acellular biological material chemically treated with genipin
|
US20060171907A1
(en)
*
|
1996-11-21 |
2006-08-03 |
The Procter & Gamble Company |
Oral care compositions providing enhanced whitening and stain prevention
|
DE69738841D1
(en)
*
|
1996-12-23 |
2008-08-28 |
Immunex Corp |
LIGAND FOR RECEPTOR ACTIVATOR OF NF-KAPPA B, LIGAND IS A MEMBER OF THE TNF SUPERFAMILY
|
US7285267B2
(en)
*
|
1997-01-14 |
2007-10-23 |
Human Genome Sciences, Inc. |
Tumor necrosis factor receptors 6α & 6β
|
CN1247567A
(en)
*
|
1997-01-14 |
2000-03-15 |
人体基因组科学有限公司 |
Tumor necrosis factor receptor alfa 6 and receptor beta 6
|
US20040013664A1
(en)
*
|
1997-01-14 |
2004-01-22 |
Gentz Reiner L. |
Tumor necrosis factor receptors 6 alpha & 6 beta
|
AU6030398A
(en)
*
|
1997-01-21 |
1998-08-07 |
Auckland Uniservices Limited |
Human proteins
|
US20030165467A1
(en)
*
|
1997-01-21 |
2003-09-04 |
Technion Research & Development Co., Ltd. |
Angiogenic factor and use thereof in treating cardiovascular disease
|
US20020155538A1
(en)
*
|
1997-01-23 |
2002-10-24 |
Incyte Pharmaceuticals, Inc. |
Novel endothelial growth factor
|
WO1998033918A1
(en)
*
|
1997-02-05 |
1998-08-06 |
The Regents Of The University Of California |
Morphogenic proteins
|
WO1998035039A1
(en)
*
|
1997-02-06 |
1998-08-13 |
Human Genome Sciences, Inc. |
Dendritic cell-derived growth factor
|
US6395707B1
(en)
|
1997-02-14 |
2002-05-28 |
Genentech, Inc. |
Methods of treatment utilizing variants of vascular endothelial cell growth factor
|
US6485942B1
(en)
|
1997-02-14 |
2002-11-26 |
Genentech, Inc. |
Variants of vascular endothelial cell growth factor having altered pharmacological properties, and recombinant methods of production
|
US6951924B2
(en)
*
|
1997-03-14 |
2005-10-04 |
Human Genome Sciences, Inc. |
Antibodies against secreted protein HTEBYII
|
US7968689B2
(en)
*
|
1997-03-07 |
2011-06-28 |
Human Genome Sciences, Inc. |
Antibodies to HSDEK49 polypeptides
|
WO1998039035A1
(en)
|
1997-03-07 |
1998-09-11 |
The Wistar Institute Of Anatomy & Biology |
Method and compositions for healing tissue defects and inducing hypervascularity in mammalian tissue
|
US20060084082A1
(en)
|
1997-03-07 |
2006-04-20 |
Human Genome Sciences, Inc. |
186 human secreted proteins
|
WO2000035937A1
(en)
*
|
1998-12-17 |
2000-06-22 |
Human Genome Sciences, Inc. |
47 human secreted proteins
|
US7196164B2
(en)
*
|
1997-07-08 |
2007-03-27 |
Human Genome Sciences, Inc. |
Secreted protein HHTLF25
|
US6541212B2
(en)
*
|
1997-03-10 |
2003-04-01 |
The Regents Of The University Of California |
Methods for detecting prostate stem cell antigen protein
|
US5935813A
(en)
*
|
1997-03-20 |
1999-08-10 |
Incyte Pharmaceuticals, Inc. |
Human pancreatitis-associated protein
|
US20020137890A1
(en)
*
|
1997-03-31 |
2002-09-26 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
EP1005355A4
(en)
*
|
1997-04-15 |
2002-07-17 |
Radix Organization Inc |
Method of treating gastrointestinal ulcers and compositions therefor
|
US7205381B2
(en)
*
|
1997-04-21 |
2007-04-17 |
Schering Corporation |
Mammalian cytokines; related reagents and methods
|
US20030166065A1
(en)
*
|
1997-04-24 |
2003-09-04 |
Human Genome Sciences, Inc. |
Novel integrin ligand ITGL-TSP
|
US7220557B2
(en)
*
|
1997-04-24 |
2007-05-22 |
Human Genome Sciences, Inc. |
METH1 polynucleotides
|
EP0979282A1
(en)
*
|
1997-04-30 |
2000-02-16 |
F. Hoffmann-La Roche Ag |
Rat st38.2 chemokine
|
US6342369B1
(en)
*
|
1997-05-15 |
2002-01-29 |
Genentech, Inc. |
Apo-2-receptor
|
US6506569B1
(en)
*
|
1997-05-30 |
2003-01-14 |
Human Genome Sciences, Inc. |
Antibodies to human tumor necrosis factor receptor TR10
|
US6031155A
(en)
*
|
1997-06-05 |
2000-02-29 |
Cameron-Mills; Verena |
Arabinoxylan degradation
|
US20060223077A1
(en)
*
|
1997-06-06 |
2006-10-05 |
Human Genome Sciences, Inc. |
207 human secreted proteins
|
US5891674A
(en)
*
|
1997-06-19 |
1999-04-06 |
Incyte Pharmaceuticals, Inc. |
Insulin receptor tyrosine kinase substrate
|
CA2295303A1
(en)
*
|
1997-06-27 |
1999-01-07 |
Human Genome Sciences Inc. |
Human nk-3 related prostate specific gene-1
|
US6635480B1
(en)
*
|
1997-07-31 |
2003-10-21 |
The Johns Hopkins University School Of Medicine |
Growth differentiation factor, lefty-2
|
AU8586198A
(en)
*
|
1997-07-31 |
1999-02-22 |
Johns Hopkins University School Of Medicine, The |
Growth differentiation factor, lefty-1
|
AU8591198A
(en)
*
|
1997-07-31 |
1999-02-22 |
Johns Hopkins University School Of Medicine, The |
Growth differentiation factor-15
|
WO1999025825A2
(en)
*
|
1997-11-13 |
1999-05-27 |
Genset |
EXTENDED cDNAs FOR SECRETED PROTEINS
|
US6416973B1
(en)
*
|
1997-08-01 |
2002-07-09 |
Schering Corporation |
Nucleic acids encoding mammalian cell membrane protein MDL-1
|
US20020112251A1
(en)
*
|
1997-08-04 |
2002-08-15 |
Mccarthy Sean A. |
Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic and other uses
|
FR2767135B1
(en)
*
|
1997-08-06 |
2002-07-12 |
Genset Sa |
LSR COMPLEX RECEPTOR, ACTIVITY, CLONING, AND APPLICATION TO DIAGNOSIS, PREVENTION AND / OR TREATMENT OF OBESITY AND THE RISKS OR COMPLICATIONS THEREOF
|
US20040213789A1
(en)
*
|
1997-09-02 |
2004-10-28 |
Oron Yacoby-Zeevi |
Heparanase activity neutralizing anti-heparanase monoclonal antibody and other anti-heparanase antibodies
|
US20020088019A1
(en)
*
|
1997-09-02 |
2002-07-04 |
Oron Yacoby-Zeevi |
Methods of and pharmaceutical compositions for improving implantation of embryos
|
US6177545B1
(en)
*
|
1997-09-02 |
2001-01-23 |
Insight Strategy & Marketing Ltd. |
Heparanase specific molecular probes and their use in research and medical applications
|
US20010006630A1
(en)
*
|
1997-09-02 |
2001-07-05 |
Oron Yacoby-Zeevi |
Introducing a biological material into a patient
|
US20030161823A1
(en)
*
|
1998-08-31 |
2003-08-28 |
Neta Ilan |
Therapeutic and cosmetic uses of heparanases
|
US6699672B1
(en)
|
1997-09-02 |
2004-03-02 |
Insight Biopharmaceuticals Ltd. |
Heparanase specific molecular probes and their use research and medical applications
|
US6849719B2
(en)
*
|
1997-09-17 |
2005-02-01 |
Human Genome Sciences, Inc. |
Antibody to an IL-17 receptor like protein
|
US6482923B1
(en)
*
|
1997-09-17 |
2002-11-19 |
Human Genome Sciences, Inc. |
Interleukin 17-like receptor protein
|
AU9482498A
(en)
*
|
1997-09-17 |
1999-04-05 |
Human Genome Sciences, Inc. |
Interleukin-17 receptor-like protein
|
US20030077654A1
(en)
*
|
1997-09-17 |
2003-04-24 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
EP1018551A4
(en)
*
|
1997-09-22 |
2003-07-23 |
Toshio Miyata |
Megsin protein
|
US7321023B2
(en)
*
|
1997-11-07 |
2008-01-22 |
Incyte Corporation |
SP16 protein
|
US6392019B1
(en)
|
1997-11-22 |
2002-05-21 |
John Ford |
Antibodies specific for EGF motif proteins
|
US6808890B2
(en)
*
|
1999-07-28 |
2004-10-26 |
Nuvelo, Inc. |
Method of detecting a cancerous cell expressing EGFL6, and EGF mutif protein
|
US20060286639A1
(en)
*
|
1997-11-13 |
2006-12-21 |
Serono Genetics Institute S.A. |
Complementary DNAs encoding proteins with signal peptides
|
US20060009633A9
(en)
*
|
1997-11-13 |
2006-01-12 |
Genset, S.A. |
Complementary DNAs encoding proteins with signal peptides
|
AU763012B2
(en)
|
1997-11-22 |
2003-07-10 |
Arca Biopharma, Inc. |
A novel EGF motif protein obtained from a cDNA library of fetal liver-spleen
|
US20030096742A1
(en)
*
|
1997-12-03 |
2003-05-22 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
WO1999029854A1
(en)
*
|
1997-12-08 |
1999-06-17 |
Ontogeny, Inc. |
Human patched genes and proteins, and uses related thereto
|
US6303770B1
(en)
*
|
1997-12-10 |
2001-10-16 |
Zymogenetics, Inc. |
Nucleic acids encoding mammalian alpha helical protein-1
|
EP1041996A4
(en)
*
|
1997-12-22 |
2003-05-14 |
Human Genome Sciences Inc |
Keratinocyte growth factor-2 formulations
|
US6869927B1
(en)
|
1997-12-22 |
2005-03-22 |
Human Genome Sciences, Inc. |
Keratinocyte growth factor-2 formulations
|
US6703485B2
(en)
*
|
1997-12-23 |
2004-03-09 |
The Trustees Of Columbia University In The City Of New York |
Brain and heart cyclic nucleotide gated ion channel compounds and uses thereof
|
ATE395928T1
(en)
*
|
1997-12-24 |
2008-06-15 |
Ludwig Inst Cancer Res |
EXPRESSION VECTORS AND CELL LINES FOR EXPRESSING VASCULAR GROWTH FACTOR D, AND METHOD FOR TREATING MELANOMAS
|
JPH11187884A
(en)
*
|
1997-12-26 |
1999-07-13 |
Hsp Kenkyusho:Kk |
Beat shock transcription factor-binding protein
|
US6297367B1
(en)
*
|
1997-12-30 |
2001-10-02 |
Chiron Corporation |
Polynucleotide encoding TNFL1
|
AU2451199A
(en)
*
|
1998-01-07 |
1999-07-26 |
Human Genome Sciences, Inc. |
36 human secreted proteins
|
US20030170213A1
(en)
*
|
1998-01-23 |
2003-09-11 |
Marc F. Charette |
Methods and compositions for enhancing cognitive function using morphogenic proteins
|
US7722671B1
(en)
|
1998-01-27 |
2010-05-25 |
St. Jude Medical, Inc. |
Medical devices with associated growth factors
|
ES2293473T3
(en)
|
1998-02-05 |
2008-03-16 |
Biosense Webster, Inc. |
INTRACARDIAC ADMINISTRATION OF FARMACO.
|
US20030113303A1
(en)
*
|
1998-02-05 |
2003-06-19 |
Yitzhack Schwartz |
Homing of embryonic stem cells to a target zone in tissue using active therapeutics or substances
|
US20030129750A1
(en)
*
|
1998-02-05 |
2003-07-10 |
Yitzhack Schwartz |
Homing of donor cells to a target zone in tissue using active therapeutics or substances
|
NZ505955A
(en)
|
1998-02-06 |
2005-04-29 |
Collateral Therapeutics Inc |
Variants of the angiogenic factor vascular endothelial cell growth factor: VEGF-A, and pharmaceutical use
|
US6706869B1
(en)
*
|
1998-02-11 |
2004-03-16 |
Wyeth |
Map kinase phosphatases and polynucleotides encoding them
|
US6395890B1
(en)
*
|
1998-02-20 |
2002-05-28 |
Zymogenetics, Inc. |
Nucleic acids encoding connective tissue growth factor homologs
|
US6054276A
(en)
|
1998-02-23 |
2000-04-25 |
Macevicz; Stephen C. |
DNA restriction site mapping
|
US7579160B2
(en)
*
|
1998-03-18 |
2009-08-25 |
Corixa Corporation |
Methods for the detection of cervical cancer
|
US20050026248A1
(en)
*
|
1998-03-26 |
2005-02-03 |
Hsueh Aaron J.W. |
Novel mammalian G-protein coupled receptors having extracellular leucine rich repeat regions
|
DE19813774A1
(en)
*
|
1998-03-27 |
1999-09-30 |
Max Planck Gesellschaft |
Parapox virus-encoded vascular endothelial cell growth factor (PPV-VEGF)
|
US6573095B1
(en)
*
|
1998-04-29 |
2003-06-03 |
Genesis Research & Development Corporation Limited |
Polynucleotides isolated from skin cells
|
KR20010043583A
(en)
*
|
1998-05-14 |
2001-05-25 |
우에노 도시오 |
NOVEL POLYPEPTIDES, cDNAS ENCODING THE SAME AND UTILIZATION THEREOF
|
US7125959B2
(en)
*
|
1998-05-15 |
2006-10-24 |
Genentech, Inc. |
PRO4405 polypeptides
|
CA2329274A1
(en)
*
|
1998-05-29 |
1999-12-02 |
Steven M. Ruben |
Interleukin-21
|
US20010023070A1
(en)
*
|
1998-05-29 |
2001-09-20 |
Reinhard Ebner |
Interleukins-21 and 22
|
AU4411499A
(en)
*
|
1998-06-05 |
1999-12-20 |
Human Genome Sciences, Inc. |
Connective tissue growth factor-4
|
US20070020724A1
(en)
|
1998-06-16 |
2007-01-25 |
Ruben Steven M |
94 human secreted proteins
|
SK287361B6
(en)
*
|
1998-07-14 |
2010-08-09 |
Janssen Pharmaceutica N. V. |
Human neurotrophic growth factor and use thereof
|
US7067473B1
(en)
*
|
1998-07-14 |
2006-06-27 |
Janssen Pharmaceutica N.V. |
Neurotrophic growth factor
|
US20070014787A1
(en)
|
1998-07-15 |
2007-01-18 |
Human Genome Sciences, Inc. |
71 human secreted proteins
|
US20050048612A1
(en)
*
|
1998-07-28 |
2005-03-03 |
Incyte Corporation |
Human epidermal proteins HEP1-1 to HEP1-6
|
US6706951B1
(en)
*
|
1998-08-17 |
2004-03-16 |
Pioneer Hi-Bred International, Inc. |
Maize nucleic acid encoding a GDP-mannose pyrophosphorylase
|
WO2000011199A1
(en)
*
|
1998-08-20 |
2000-03-02 |
Pioneer Hi-Bred International, Inc. |
COMPOSITIONS AND METHODS FOR ALTERING AN ACETYL-CoA METABOLIC PATHWAY OF A PLANT
|
US20030217375A1
(en)
*
|
1998-08-31 |
2003-11-20 |
Eyal Zcharia |
Transgenic animals expressing heparanase and uses thereof
|
WO2000012707A1
(en)
*
|
1998-09-02 |
2000-03-09 |
Millennium Pharmaceuticals, Inc. |
14926 receptor, a novel g-protein coupled receptor
|
US7030083B2
(en)
*
|
1998-09-09 |
2006-04-18 |
University Of Washington |
Treatment of eclampsia and preeclampsia
|
EP1417971A3
(en)
*
|
1998-09-09 |
2004-06-30 |
Scios Inc. |
Use of an angiogenic factor for the treatment of microvascular angiopathies
|
EP1112083B1
(en)
*
|
1998-09-09 |
2003-11-12 |
Scios Inc. |
Use of an angiogenic factor for the treatment of microvascular angiopathies
|
JP2002525054A
(en)
*
|
1998-09-17 |
2002-08-13 |
インサイト・ファーマスーティカルズ・インコーポレイテッド |
Human GPCR protein
|
US6680380B1
(en)
*
|
1998-09-18 |
2004-01-20 |
Schering Corporation |
Nucleic acids encoding mammalian interleukin-1ζ, related reagents and methods
|
US20040058355A1
(en)
*
|
1998-09-30 |
2004-03-25 |
Millennium Pharmaceuticals, Inc. |
Novel 21910, 56634, 55053, 2504, 15977, 14760, 25501, 17903, 3700, 21529, 26176, 26343, 56638, 18610, 33217, 21967, H1983, M1983, 38555 or 593 molecules and uses therefor
|
JP2002525117A
(en)
*
|
1998-09-30 |
2002-08-13 |
ミレニアム・フアーマシユーチカルズ・インコーポレーテツド |
SLGP protein and nucleic acid molecules and uses thereof
|
JP2002527401A
(en)
*
|
1998-10-13 |
2002-08-27 |
カイロン コーポレイション |
Angiogenically effective unit dose of FGF and method of administration
|
US6440934B1
(en)
|
1998-10-13 |
2002-08-27 |
Chiron Corporation |
Angiogenically effective unit dose of FGF-2 and method of use
|
US20030166550A1
(en)
|
1999-08-27 |
2003-09-04 |
Chiron Corporation |
Angiogenically effective unit dose of FGF-2 and method of use
|
US20020072489A1
(en)
*
|
1998-10-13 |
2002-06-13 |
Whitehouse Martha J. |
Angiogenically effective unit dose of FGF-2 and method of use
|
AU1716200A
(en)
*
|
1998-11-12 |
2000-06-05 |
Human Genome Sciences, Inc. |
31 human secreted proteins
|
US6375680B1
(en)
|
1998-12-01 |
2002-04-23 |
St. Jude Medical, Inc. |
Substrates for forming synthetic tissues
|
US6783953B1
(en)
|
1998-12-22 |
2004-08-31 |
Janssen Pharmaceutica N.V. |
Vascular endothelial growth factor-X
|
JP2000189171A
(en)
*
|
1998-12-25 |
2000-07-11 |
Banyu Pharmaceut Co Ltd |
New guanosine triphosphate(gtp)-binding protein conjugated receptor protein
|
US20030009013A1
(en)
*
|
1998-12-30 |
2003-01-09 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
AU2856400A
(en)
*
|
1999-01-25 |
2000-08-07 |
University Of Florida |
Materials and methods for producing geminivirus resistant plants
|
AU3590000A
(en)
*
|
1999-02-02 |
2000-08-25 |
Trustees Of Columbia University In The City Of New York, The |
Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof
|
US7223724B1
(en)
*
|
1999-02-08 |
2007-05-29 |
Human Genome Sciences, Inc. |
Use of vascular endothelial growth factor to treat photoreceptor cells
|
JP2002540763A
(en)
*
|
1999-02-10 |
2002-12-03 |
ヒューマン ジノーム サイエンシーズ, インコーポレイテッド |
33 human secreted proteins
|
DE19906096A1
(en)
*
|
1999-02-13 |
2000-08-17 |
Walter Sebald |
Protein with a heparin-binding epitope
|
US6392126B1
(en)
*
|
1999-02-25 |
2002-05-21 |
Pioneer Hi-Bred International, Inc. |
Adenosine deaminase homologues and uses thereof
|
US7083793B2
(en)
*
|
1999-02-26 |
2006-08-01 |
Millennium Pharmaceuticals, Inc. |
Tango 243 polypeptides and uses thereof
|
US6406907B1
(en)
*
|
1999-02-26 |
2002-06-18 |
Iowa State University Research Foundation |
Bovine tumor necrosis factor receptor-1 and methods of use
|
AU2878600A
(en)
*
|
1999-03-01 |
2000-09-21 |
Hadasit Medical Research Services & Development Company Ltd |
Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells
|
IL128852A0
(en)
*
|
1999-03-05 |
2000-01-31 |
Compugen Ltd |
Novel nucleic acid and amino acid sequences
|
US6783954B2
(en)
*
|
1999-03-05 |
2004-08-31 |
Compugen Ltd. |
VEGF nucleic acid and amino acid sequences
|
US6689866B1
(en)
*
|
1999-03-09 |
2004-02-10 |
Curagen Corporation |
Polynucleotides and proteins encoded thereby
|
US8410248B2
(en)
*
|
1999-03-12 |
2013-04-02 |
Human Genome Sciences Inc. |
HWBAO62 polypeptides
|
US8133734B2
(en)
*
|
1999-03-16 |
2012-03-13 |
Human Genome Sciences, Inc. |
Kit comprising an antibody to interleukin 17 receptor-like protein
|
US6965012B1
(en)
*
|
1999-03-30 |
2005-11-15 |
Eli Lilly And Company |
Flint polypeptide analogs
|
WO2000061757A1
(en)
*
|
1999-04-12 |
2000-10-19 |
Genentech, Inc. |
Tumor necrosis factor homologs and nucleic acids encoding the same
|
US7345019B1
(en)
*
|
1999-04-13 |
2008-03-18 |
The Kenneth S. Warren Institute, Inc. |
Modulation of excitable tissue function by peripherally administered erythropoietin
|
AU4662400A
(en)
*
|
1999-04-26 |
2000-11-10 |
Helsinki University Licensing Ltd |
Role of vascular endothelial growth factor-b (vegf-b) in developing bones and uses thereof
|
IL145941A
(en)
|
1999-04-28 |
2007-08-19 |
Univ Texas |
Compositions and methods for cancer treatment by selectively inhibiting vegf
|
CA2371702A1
(en)
*
|
1999-04-30 |
2000-11-09 |
Toshio Miyata |
Meg-3 protein
|
WO2000068378A1
(en)
*
|
1999-05-06 |
2000-11-16 |
National Jewish Medical And Research Center |
Tall-1 nucleic acid molecules, proteins, receptors and methods of use thereof
|
CA2373822A1
(en)
|
1999-05-20 |
2000-11-30 |
Scios Inc. |
Vascular endothelial growth factor variants
|
JP2003500053A
(en)
*
|
1999-05-20 |
2003-01-07 |
サイオス,インコーポレーテッド |
Vascular endothelial growth factor dimer
|
WO2000071577A1
(en)
*
|
1999-05-25 |
2000-11-30 |
Human Genome Sciences, Inc. |
Meth1 and meth2 polynucleotides and polypeptides
|
US20030207793A1
(en)
*
|
1999-05-26 |
2003-11-06 |
Conklin Darrell C. |
Secreted alpha-helical protein - 32
|
JP2003501072A
(en)
*
|
1999-06-07 |
2003-01-14 |
ヒューマン ジノーム サイエンシーズ, インコーポレイテッド |
26 human secreted proteins
|
US6781028B1
(en)
*
|
1999-06-14 |
2004-08-24 |
Exelixis, Inc. |
Animal models and methods for analysis of lipid metabolism and screening of pharmaceutical and pesticidal agents that modulate lipid metabolism
|
US20030153050A1
(en)
*
|
1999-06-28 |
2003-08-14 |
Conklin Darrell C. |
Helical polypeptide zalpha29
|
US20030096355A1
(en)
*
|
1999-07-09 |
2003-05-22 |
Ke Zhang |
Isolation, identification and characterization of ymkz5, a novel member of the TNF-receptor supergene family
|
US6951738B2
(en)
*
|
1999-07-16 |
2005-10-04 |
Human Genome Sciences, Inc. |
Human tumor necrosis factor receptors TR13 and TR14
|
CA2696819C
(en)
*
|
1999-07-23 |
2015-07-07 |
Kenji Kangawa |
Ghrelin related peptides
|
WO2001010891A2
(en)
*
|
1999-08-05 |
2001-02-15 |
Research Corporation Technologies, Inc. |
Il-16 antagonists
|
US20030134788A1
(en)
*
|
1999-08-12 |
2003-07-17 |
Baker Kevin P. |
Human tumor necrosis factor receptor TR16
|
US20040214783A1
(en)
*
|
2002-05-08 |
2004-10-28 |
Terman David S. |
Compositions and methods for treatment of neoplastic disease
|
KR100510795B1
(en)
*
|
1999-08-31 |
2005-08-30 |
|
Compositions and Methods for the Treatment of Tumor
|
US20030120037A1
(en)
*
|
1999-09-22 |
2003-06-26 |
Ji Ming Wang |
Utilization of FPRL1 as a functional receptor by serum amyloid a (SAA)
|
USRE39849E1
(en)
|
1999-10-12 |
2007-09-18 |
Chemocentryx, Inc. |
Methods for identifying modulators of CCX CKR activity
|
US6998239B1
(en)
*
|
1999-10-12 |
2006-02-14 |
Chemocentryx, Inc. |
Method for identifying a modulator of the binding of CCX CKR polypeptide to a chemokine
|
DE60039708D1
(en)
*
|
1999-10-18 |
2008-09-11 |
Lexicon Pharmaceuticals Inc |
HUMAN CHORDIN AND POLYNUCLEOTIDES THAT CODE FOR THIS
|
US7459308B2
(en)
*
|
1999-10-21 |
2008-12-02 |
Arbor Vita Corporation |
Nucleic acid molecule encoding a CLASP-2 transmembrane protein
|
US6726718B1
(en)
|
1999-12-13 |
2004-04-27 |
St. Jude Medical, Inc. |
Medical articles prepared for cell adhesion
|
US7029857B1
(en)
*
|
1999-12-17 |
2006-04-18 |
H. Lundbeck A/S |
Processes for obtaining compounds employing SNORF72 receptors
|
JP2001211886A
(en)
*
|
2000-02-07 |
2001-08-07 |
Japan Science & Technology Corp |
Non-sodium-dependent small neutral amino acid transporter transporting l- and d-amino acids and its gene
|
CA2399387C
(en)
*
|
2000-02-11 |
2015-11-03 |
Biogen, Inc. |
Heterologous polypeptide of the tnf family
|
ATE377081T1
(en)
|
2000-02-25 |
2007-11-15 |
Ludwig Inst Cancer Res |
MATERIALS AND METHODS CONTAINING HYBRID VASCULAR DOTHELIAL GROWTH FACTORS DNA AND PROTEINS AND SCREENING METHODS FOR MODULATORS
|
US20030165891A1
(en)
*
|
2000-02-29 |
2003-09-04 |
Millennium Pharmaceuticals, Inc. |
Novel TWIK-6, TWIK-7, IC23927, TWIK-8, IC47611, IC47615, HNMDA-1, TWIK-9 alpha2delta-4, 54414, and 53763 molecules and uses therefor
|
US6794187B2
(en)
*
|
2000-03-03 |
2004-09-21 |
University Of Utah Research Foundation |
Mass1 gene, a target for anticonvulsant drug development
|
US7514239B2
(en)
*
|
2000-03-28 |
2009-04-07 |
Amgen Inc. |
Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptides and heterodimers thereof
|
US20030119739A1
(en)
*
|
2000-03-29 |
2003-06-26 |
Beth Israel Deaconess Medical Center |
Anti-angiogenic and anti-tumor properties of Vascostatin and other nidogen domains
|
US7070946B2
(en)
*
|
2000-05-23 |
2006-07-04 |
Tanabe Seiyaku Co., Ltd. |
Bone metabolism related protein and gene thereof
|
AU2001241713C1
(en)
*
|
2000-05-31 |
2006-11-30 |
Ortho-Mcneil Pharmaceutical, Inc. |
DNAs encoding mammalian histamine receptor of the H4 subtype
|
US20030059461A1
(en)
*
|
2000-06-06 |
2003-03-27 |
Sibtech, Inc. |
Molecular delivery vehicle for delivery of selected compounds to targets
|
US7355019B2
(en)
*
|
2000-06-06 |
2008-04-08 |
Sibtech, Inc. |
Cysteine-containing peptide tag for site-specific conjugation of proteins
|
AU8183601A
(en)
*
|
2000-06-21 |
2002-01-02 |
Merck Patent Gmbh |
A g-protein coupled receptor
|
EP1313512A4
(en)
*
|
2000-08-04 |
2004-08-25 |
Human Genome Sciences Inc |
Vascular endothelial growth factor 2
|
US20020081700A1
(en)
*
|
2000-08-07 |
2002-06-27 |
Sheppard Paul O. |
Snake venom polypeptide zsnk1
|
JP2004508043A
(en)
*
|
2000-09-05 |
2004-03-18 |
アムジェン インコーポレイテッド |
TNF receptor-like molecules and uses thereof
|
AU2002213259A1
(en)
*
|
2000-10-13 |
2002-04-22 |
Hyseq, Inc. |
Egf motif protein, egfl6 materials and methods
|
US6489456B1
(en)
*
|
2000-10-27 |
2002-12-03 |
Pe Corporation (Ny) |
Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
|
GB0028971D0
(en)
*
|
2000-11-28 |
2001-01-10 |
Inpharmatica Ltd |
Novel proteins
|
US7067317B2
(en)
*
|
2000-12-07 |
2006-06-27 |
Sangamo Biosciences, Inc. |
Regulation of angiogenesis with zinc finger proteins
|
AU2002228841C1
(en)
*
|
2000-12-07 |
2006-11-23 |
Sangamo Biosciences, Inc |
Regulation of angiogenesis with zinc finger proteins
|
US20040072997A1
(en)
*
|
2000-12-20 |
2004-04-15 |
Alsobrook John P. |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
US7767643B2
(en)
|
2000-12-29 |
2010-08-03 |
The Kenneth S. Warren Institute, Inc. |
Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs
|
US20030072737A1
(en)
*
|
2000-12-29 |
2003-04-17 |
Michael Brines |
Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
|
US20030180309A1
(en)
*
|
2001-01-08 |
2003-09-25 |
Baum Peter R. |
Human B7 polypeptides
|
US20030186904A1
(en)
*
|
2001-01-08 |
2003-10-02 |
Human Genome Sciences, Inc. |
Keratinocyte growth factor-2
|
US7442370B2
(en)
*
|
2001-02-01 |
2008-10-28 |
Biogen Idec Ma Inc. |
Polymer conjugates of mutated neublastin
|
WO2002068587A2
(en)
*
|
2001-02-07 |
2002-09-06 |
Bristol-Myers Squibb Company |
Polynucleotide encoding a novel human potassium channel beta-subunit, k+betam3
|
TW200526779A
(en)
*
|
2001-02-08 |
2005-08-16 |
Wyeth Corp |
Modified and stabilized GDF propeptides and uses thereof
|
CA2438934A1
(en)
*
|
2001-02-23 |
2002-09-06 |
Wyeth |
Chondrogenic potential of human bone marrow-derived cd105+ cells by bmp
|
US7276580B2
(en)
*
|
2001-03-12 |
2007-10-02 |
Biogen Idec Ma Inc. |
Neurotrophic factors
|
US7741049B2
(en)
*
|
2001-03-15 |
2010-06-22 |
Sumitomo Chemical Company, Limited |
Analysis of agonist-activity and antagonist-activity to cytokinin receptor
|
US6962971B2
(en)
*
|
2001-03-16 |
2005-11-08 |
The Regents Of The University Of California |
Chemokines and methods for inducing the differentiation of fibroblasts to myofibroblasts
|
EP1372698A2
(en)
*
|
2001-03-23 |
2004-01-02 |
BIOPHARM GESELLSCHAFT ZUR BIOTECHNOLOGISCHEN ENTWICKLUNG VON PHARMAKA mbH |
Use of cytokines of the tgf-beta superfamily for the treatment and diagnosis of skin related disorders
|
AU2002303340A1
(en)
*
|
2001-04-10 |
2002-10-28 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer
|
US20030027751A1
(en)
*
|
2001-04-10 |
2003-02-06 |
Genvec, Inc. |
VEGF fusion proteins
|
US7795218B2
(en)
*
|
2001-04-12 |
2010-09-14 |
Bioaxone Therapeutique Inc. |
ADP-ribosyl transferase fusion variant proteins
|
CA2444632A1
(en)
*
|
2001-04-13 |
2002-10-24 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2
|
EP1385862A4
(en)
*
|
2001-04-13 |
2005-03-02 |
Human Genome Sciences Inc |
Vascular endothelial growth factor 2
|
US20050232921A1
(en)
*
|
2001-04-13 |
2005-10-20 |
Rosen Craig A |
Vascular endothelial growth factor 2
|
US20030170786A1
(en)
*
|
2001-04-13 |
2003-09-11 |
Rosen Craig A. |
Vascular endothelial growth factor 2
|
US7402312B2
(en)
*
|
2001-04-13 |
2008-07-22 |
Human Genome Sciences, Inc. |
Antibodies to vascular endothelial growth factor 2 (VEGF-2)
|
US6660737B2
(en)
|
2001-05-04 |
2003-12-09 |
The Procter & Gamble Company |
Medicinal uses of hydrazones
|
US6878729B2
(en)
|
2001-05-04 |
2005-04-12 |
The Procter & Gamble Company |
Medicinal uses of dihydropyrazoles
|
GB0119015D0
(en)
*
|
2001-08-03 |
2001-09-26 |
Univ Cardiff |
A fusion protein
|
US20030086872A1
(en)
*
|
2001-08-15 |
2003-05-08 |
Jean-Philippe Girard |
SUT-2 and SUT-3 genes, proteins and assays for inhibitors of lymphocyte adhesion
|
MXPA04001526A
(en)
*
|
2001-08-21 |
2004-05-31 |
Chiron Corp |
Kgf polypeptide compositions.
|
AU2002331669A1
(en)
*
|
2001-08-23 |
2003-03-10 |
The Wistar Institute Of Anatomy And Biology |
An organotypic intestinal culture and methods of use thereof
|
MXPA04001986A
(en)
*
|
2001-08-29 |
2004-06-07 |
Genentech Inc |
Compositions and methods for the treatment of immune related diseases.
|
US20050222070A1
(en)
*
|
2002-05-29 |
2005-10-06 |
Develogen Aktiengesellschaft Fuer Entwicklungsbiologische Forschung |
Pancreas-specific proteins
|
US20040214766A1
(en)
*
|
2001-10-01 |
2004-10-28 |
Kari Alitalo |
VEGF-C or VEGF-D materials and methods for treatment of neuropathologies
|
US20040031067A1
(en)
*
|
2001-10-11 |
2004-02-12 |
Meenhard Herlyn |
Regulation of human skin healing
|
US7097990B2
(en)
*
|
2001-10-12 |
2006-08-29 |
Astellas Pharma Inc. |
Method of screening cell death inhibitor
|
EP1578907A2
(en)
*
|
2001-10-17 |
2005-09-28 |
ZymoGenetics, Inc. |
Secreted protein, ztnf9
|
US7371258B2
(en)
*
|
2001-10-26 |
2008-05-13 |
St. Jude Medical, Inc. |
Valved prosthesis with porous substrate
|
US6671189B2
(en)
*
|
2001-11-09 |
2003-12-30 |
Minebea Co., Ltd. |
Power converter having primary and secondary side switches
|
US20030093147A1
(en)
*
|
2001-11-13 |
2003-05-15 |
Ogle Matthew F. |
Medical devices that stimulate growth factor production
|
US20050137130A1
(en)
*
|
2001-11-14 |
2005-06-23 |
Bodmer Mark W. |
Medical treatment
|
EP1474176A4
(en)
*
|
2001-11-26 |
2005-06-15 |
Bristol Myers Squibb Co |
Novel human g-protein coupled receptor, hgprbmy31, and variants and methods of use thereof
|
US20030104496A1
(en)
*
|
2001-11-30 |
2003-06-05 |
Cytokinetics, Inc. |
Novel motor protein of P. falciparum and methods for its use
|
US20030171556A1
(en)
*
|
2001-12-13 |
2003-09-11 |
Chi-Bom Chae |
Beta-amyloid binding factors and inhibitors thereof
|
US7795213B2
(en)
*
|
2001-12-13 |
2010-09-14 |
Posco |
Methods of contacting β amyloid protein with VEGF
|
CA2472927A1
(en)
*
|
2002-01-10 |
2003-07-17 |
Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw |
A novel splice variant of myd88 and uses thereof
|
US20040162237A1
(en)
*
|
2002-01-15 |
2004-08-19 |
Fox Niles Wayne |
Use of lp82 to treat body weight disorders
|
KR20030062789A
(en)
|
2002-01-19 |
2003-07-28 |
포휴먼텍(주) |
Biomolecule transduction peptide sim2-btm and biotechnological products including it
|
KR20030062788A
(en)
|
2002-01-19 |
2003-07-28 |
포휴먼텍(주) |
Biomolecule transduction peptide mph1-btm and biotechnological products including it
|
WO2003066808A2
(en)
*
|
2002-01-23 |
2003-08-14 |
Texas Tech University |
Mammalian migration inducting gene and methods for detection and inhibition of migrating tumor cells
|
EP1474515A2
(en)
*
|
2002-02-01 |
2004-11-10 |
Bayer HealthCare AG |
Regulation of human hematopoietin receptor-like protein
|
GB0202906D0
(en)
|
2002-02-07 |
2002-03-27 |
Univ London |
Prevention of myocardial damage
|
WO2003077652A1
(en)
*
|
2002-03-12 |
2003-09-25 |
Harold Brem |
Method for treating diabetic ulcers
|
US20060263770A1
(en)
*
|
2002-03-22 |
2006-11-23 |
Marco Colonna |
Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
|
JP2005537783A
(en)
*
|
2002-03-28 |
2005-12-15 |
ザ ジェネティクス カンパニー インコーポレイティド |
Growth regulatory protein
|
CA2482718C
(en)
*
|
2002-04-18 |
2014-08-19 |
Yeda Research And Development Co. Ltd. |
Derivatives of the il-2 receptor gamma chain, their production and use
|
WO2003091282A1
(en)
*
|
2002-04-24 |
2003-11-06 |
Banyu Pharmaceutical Co., Ltd. |
Histamine receptor h3 ordinary activity mutant and utilization thereof
|
US20030055221A1
(en)
*
|
2002-05-07 |
2003-03-20 |
Jirong Lu |
Stability of flint through o-linked glycosylation
|
EP1382613A1
(en)
*
|
2002-07-16 |
2004-01-21 |
Sumitomo Chemical Company, Limited |
Novel G protein, polynucleotide encoding the same and utilization thereof
|
US7335362B2
(en)
*
|
2002-07-19 |
2008-02-26 |
Beth Israel Deaconess Medical Center |
Methods of treating pre-eclampsia or eclampsia
|
US7435419B2
(en)
|
2002-07-19 |
2008-10-14 |
Beth Israel Deaconess Medical Center |
Methods of diagnosing and treating pre-eclampsia or eclampsia
|
ES2440651T3
(en)
*
|
2002-07-19 |
2014-01-29 |
Beth Israel Deaconess Medical Center |
Method to diagnose preeclampsia
|
GB0219303D0
(en)
*
|
2002-08-19 |
2002-09-25 |
Ares Trading Sa |
Protein
|
AU2003267563A1
(en)
*
|
2002-09-10 |
2004-04-30 |
Lorantis Limited |
Pharmaceutical composition and medical treatments comprising notch ligand proteins
|
BR0315155A
(en)
*
|
2002-10-08 |
2005-08-16 |
Ares Trading Sa |
Use of cytokine capable of binding to il-18bp and inhibiting the activity of a second cytokine
|
GB0223984D0
(en)
*
|
2002-10-15 |
2002-11-20 |
Novartis Forschungsstiftung |
Methods for detecting teneurin signalling and related screening methods
|
US20040223966A1
(en)
*
|
2002-10-25 |
2004-11-11 |
Wolfman Neil M. |
ActRIIB fusion polypeptides and uses therefor
|
JP4571776B2
(en)
*
|
2002-11-05 |
2010-10-27 |
Jx日鉱日石エネルギー株式会社 |
Lubricating oil composition
|
US7060684B1
(en)
|
2002-12-16 |
2006-06-13 |
Quijano Rodolfo C |
Device for treating diabetes and methods thereof
|
US20040120950A1
(en)
*
|
2002-12-20 |
2004-06-24 |
Kari Alitalo |
Modulation of VEGF-C/VEGFR-3 interactions in the treatment of rheumatoid arthritis
|
US20040235747A1
(en)
*
|
2003-01-02 |
2004-11-25 |
Ramot At Tel-Aviv University Ltd. |
Methods of treating and/or preventing autoimmune diseases
|
WO2004062621A2
(en)
*
|
2003-01-13 |
2004-07-29 |
Georgia Tech Research Corporation |
Anti-inflammatory agents and methods of their use
|
WO2004069136A2
(en)
*
|
2003-02-05 |
2004-08-19 |
Applied Research Systems Ars Holding N.V. |
Mucin-like polypeptides
|
DE602004027798D1
(en)
*
|
2003-03-12 |
2010-08-05 |
Univ Arizona State |
METHOD FOR REGULATING ANGIOGENESIS WITH APELIN COMPOSITIONS
|
US7084246B2
(en)
*
|
2003-04-17 |
2006-08-01 |
Molecular Logix, Inc. |
Epidermal growth factor agonists
|
DE602004021648D1
(en)
|
2003-04-18 |
2009-07-30 |
Biogen Idec Inc |
Polymer-conjugated glycosylated neublastin
|
TWI353991B
(en)
|
2003-05-06 |
2011-12-11 |
Syntonix Pharmaceuticals Inc |
Immunoglobulin chimeric monomer-dimer hybrids
|
US8273347B2
(en)
|
2003-05-13 |
2012-09-25 |
Depuy Spine, Inc. |
Autologous treatment of degenerated disc with cells
|
US7429378B2
(en)
*
|
2003-05-13 |
2008-09-30 |
Depuy Spine, Inc. |
Transdiscal administration of high affinity anti-MMP inhibitors
|
US7344716B2
(en)
*
|
2003-05-13 |
2008-03-18 |
Depuy Spine, Inc. |
Transdiscal administration of specific inhibitors of pro-inflammatory cytokines
|
US7553827B2
(en)
*
|
2003-08-13 |
2009-06-30 |
Depuy Spine, Inc. |
Transdiscal administration of cycline compounds
|
US20040229878A1
(en)
*
|
2003-05-13 |
2004-11-18 |
Depuy Spine, Inc. |
Transdiscal administration of specific inhibitors of P38 kinase
|
WO2005110009A2
(en)
*
|
2003-07-22 |
2005-11-24 |
Immunex Corporation |
COMPOSITIONS AND METHODS RELATING TO TSP-30a, b, c AND d
|
KR100632985B1
(en)
*
|
2003-07-26 |
2006-10-11 |
메덱스젠 주식회사 |
A method of improving efficacy of biological response-modifying proteins and the example muteins
|
US8361467B2
(en)
*
|
2003-07-30 |
2013-01-29 |
Depuy Spine, Inc. |
Trans-capsular administration of high specificity cytokine inhibitors into orthopedic joints
|
US7759472B2
(en)
*
|
2003-08-27 |
2010-07-20 |
Ophthotech Corporation |
Combination therapy for the treatment of ocular neovascular disorders
|
JP4723496B2
(en)
*
|
2003-09-08 |
2011-07-13 |
メルク セローノ ソシエテ アノニム |
Treatment of fibrotic diseases
|
WO2005026344A1
(en)
*
|
2003-09-11 |
2005-03-24 |
Hubit Genomix, Inc. |
Method and kit for detecting proliferative diseases causing sclerosis, preventive and/or remedy for proliferative diseases causing sclerosis and method and kit for identifying substance efficacious in preventing and/or treating proliferative diseases causing sclerosis
|
AU2004277954A1
(en)
*
|
2003-09-29 |
2005-04-14 |
The Kenneth S Warren Institute, Inc. |
Tissue protective cytokines for the treatment and prevention of sepsis and the formation of adhesions
|
US20060104978A1
(en)
*
|
2003-10-24 |
2006-05-18 |
Ludwig Institute For Cancer Research |
Methods and compositions for PDGF-C activation and inhibition
|
AU2004290070A1
(en)
|
2003-11-12 |
2005-05-26 |
Biogen Idec Ma Inc. |
Neonatal Fc receptor (FcRn)-binding polypeptide variants, dimeric Fc binding proteins and methods related thereto
|
WO2005051994A2
(en)
*
|
2003-11-21 |
2005-06-09 |
Zymogenetics, Inc. |
Ztnf11, a tumor necrosis factor
|
US8895540B2
(en)
*
|
2003-11-26 |
2014-11-25 |
DePuy Synthes Products, LLC |
Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
|
WO2005058957A2
(en)
*
|
2003-12-16 |
2005-06-30 |
Zymogenetics, Inc. |
Ztnf 12, a tumor necrosis factor
|
DE602004013372T2
(en)
|
2003-12-30 |
2009-07-02 |
Merck Patent Gmbh |
IL-7 FUSION PROTEINS WITH ANTIBODY PORTIONS, THEIR PREPARATION AND THEIR USE
|
US20050176073A1
(en)
*
|
2004-02-06 |
2005-08-11 |
Chemocentryx, Inc. |
Cell proliferation associated with CCX CKR expression
|
AU2005244167A1
(en)
*
|
2004-05-04 |
2005-11-24 |
Beth Israel Deaconess Medical Center |
Methods and compositions for treatment of preeclampsia
|
DE602005005392T2
(en)
*
|
2004-06-30 |
2009-04-23 |
Tyco Electronics Nederland B.V. |
Connector for electronic components
|
US7597884B2
(en)
|
2004-08-09 |
2009-10-06 |
Alios Biopharma, Inc. |
Hyperglycosylated polypeptide variants and methods of use
|
JP2008513356A
(en)
*
|
2004-08-09 |
2008-05-01 |
アリオス バイオファーマ インク. |
Synthetic advanced glycosylated protease resistant polypeptide variants, oral formulations and methods using the same
|
AU2005272653A1
(en)
*
|
2004-08-13 |
2006-02-23 |
Anormed Inc. |
Chemokine combinations to mobilize progenitor/stem cells
|
SE0402025D0
(en)
*
|
2004-08-13 |
2004-08-13 |
Active Biotech Ab |
Treatment of hyperproliferative disease with superantigens in combination with another anticancer agent
|
DE602005022457D1
(en)
*
|
2004-08-19 |
2010-09-02 |
Biogen Idec Inc |
Neublastin VARIATIONS
|
AR050608A1
(en)
*
|
2004-08-19 |
2006-11-08 |
Alza Corp |
APPARATUS AND METHOD FOR TRANSDERMAL ADMINISTRATION OF VASCULAR ENDOTELIAL GROWTH FACTORS
|
ES2349043T3
(en)
*
|
2004-08-19 |
2010-12-22 |
Biogen Idec Ma Inc. |
NEUBLASTIN VARIANTS.
|
US20070166281A1
(en)
*
|
2004-08-21 |
2007-07-19 |
Kosak Kenneth M |
Chloroquine coupled antibodies and other proteins with methods for their synthesis
|
US20080171033A1
(en)
*
|
2004-08-26 |
2008-07-17 |
Chiwen Chang |
Compositions and methods for treating diseases associated with angiogenesis and inflammation
|
US7740849B2
(en)
*
|
2004-09-24 |
2010-06-22 |
Beth Israel Deaconess Medical Center |
Use of compounds that bind soluble endoglin and SFLT-1 for the treatment of pregnancy related hypertensive disorders
|
EP1804836B1
(en)
|
2004-09-24 |
2010-11-17 |
Beth Israel Deaconess Medical Center |
Methods of diagnosing and treating complications of pregnancy
|
US20060090646A1
(en)
*
|
2004-11-04 |
2006-05-04 |
Questair Technologies Inc. |
Adsorbent material for selective adsorption of carbon monoxide and unsaturated hydrocarbons
|
US7939267B2
(en)
*
|
2004-11-04 |
2011-05-10 |
Laboratory Corporation Of America Holdings |
Detection of activation of endothelial cells as surrogate marker for angiogenesis
|
EP2377555A3
(en)
|
2004-11-18 |
2011-11-23 |
Imclone LLC |
Antibodies against vascular endothelial growth factor receptor-1
|
US20080026410A1
(en)
*
|
2004-12-02 |
2008-01-31 |
Antonia Vlahou |
Biomarkers for Bladder Cancer
|
BRPI0519096A2
(en)
*
|
2004-12-15 |
2008-12-23 |
Beth Israel Hospital |
Nucleic Acids and Polypeptides Useful for Diagnosing and Treating Pregnancy Complications
|
WO2006074397A2
(en)
|
2005-01-05 |
2006-07-13 |
Biogen Idec Ma Inc. |
Cripto binding molecules
|
ATE553122T1
(en)
|
2005-02-28 |
2012-04-15 |
Sangamo Biosciences Inc |
ANTIANGIOGENIC METHODS AND COMPOSITIONS
|
WO2006097682A1
(en)
*
|
2005-03-18 |
2006-09-21 |
Ucl Business Plc |
Mechano growth factor peptides and their use
|
CN101137906A
(en)
*
|
2005-03-23 |
2008-03-05 |
惠氏公司 |
Detection of an immune response to gdf-8 modulating agents
|
US7767789B2
(en)
*
|
2005-06-02 |
2010-08-03 |
University Hopitals of Cleveland |
Truncated proteins as cancer markers
|
MX2007015943A
(en)
*
|
2005-06-17 |
2008-03-07 |
Genentech Inc |
Wound healing.
|
JP2008547006A
(en)
*
|
2005-06-17 |
2008-12-25 |
ザ ブライハム アンド ウイメンズ ホスピタル, インコーポレイテッド |
Osteoarthritis protein profile
|
US8329175B2
(en)
*
|
2005-08-26 |
2012-12-11 |
Beth Israel Deaconess Medical Center, Inc. |
Methods and compositions for the treatment and diagnosis of endothelial cell disorders and angiogenic disorders
|
US7659250B2
(en)
*
|
2005-12-22 |
2010-02-09 |
Centocor, Inc. |
BMP-7 variant compositions, methods and uses
|
AU2006343279B2
(en)
|
2005-12-22 |
2012-03-29 |
Genentech, Inc. |
Recombinant production of heparin binding proteins
|
US20080064631A1
(en)
*
|
2006-01-13 |
2008-03-13 |
Jeffrey Molldrem |
T-cell receptors for use in diagnosis and therapy of cancers and autoimmune disease
|
TWI501774B
(en)
*
|
2006-02-27 |
2015-10-01 |
Biogen Idec Inc |
Treatments for neurological disorders
|
US20100056440A1
(en)
*
|
2006-03-01 |
2010-03-04 |
Biogen Idec Ma Inc. |
Compositions and methods for administering gdnf ligand family proteins
|
GB0604460D0
(en)
*
|
2006-03-06 |
2006-04-12 |
Isis Innovation |
Treatment
|
US9878003B2
(en)
|
2006-03-06 |
2018-01-30 |
The University Of Manchester |
Method of treating bone disorders using TSG-6
|
WO2007130619A1
(en)
*
|
2006-05-03 |
2007-11-15 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for regulating osteoclast differentiation, activation and bone resorption
|
AU2007254243B2
(en)
|
2006-05-17 |
2013-06-13 |
Ludwig Institute For Cancer Research |
Targeting VEGF-B regulation of fatty acid transporters to modulate human diseases
|
US20090286271A1
(en)
*
|
2006-05-31 |
2009-11-19 |
Karumanchi Ananth S |
Methods of Diagnosing and Treating Complications of Pregnancy
|
ES2532848T3
(en)
*
|
2006-07-04 |
2015-04-01 |
Combigene Ab |
Use of nucleic acid sequences for the treatment of neurological and psychiatric diseases, vectors and compositions
|
EP2041154B1
(en)
|
2006-07-14 |
2018-12-12 |
Genentech, Inc. |
Refolding of recombinant proteins
|
US20100178271A1
(en)
*
|
2006-08-07 |
2010-07-15 |
Genzyme Corporation |
Combination Therapy
|
US8865169B2
(en)
*
|
2007-02-20 |
2014-10-21 |
Tufts University |
Methods and systems for multi-antibody therapies
|
US9023352B2
(en)
|
2007-02-20 |
2015-05-05 |
Tufts University |
Methods, compositions and kits for treating a subject using a recombinant heteromultimeric neutralizing binding protein
|
KR100984483B1
(en)
*
|
2007-03-19 |
2010-10-01 |
(주)바이오니아 |
Cyclic reverse transcription method
|
WO2008116111A2
(en)
*
|
2007-03-20 |
2008-09-25 |
Harold Brem |
Growth factor mediated cosmeceuticals and use thereof to enhance skin quality
|
WO2008116116A2
(en)
*
|
2007-03-20 |
2008-09-25 |
Harold Brem |
Gm-csf cosmeceutical compositions and methods of use thereof
|
US20080260820A1
(en)
*
|
2007-04-19 |
2008-10-23 |
Gilles Borrelly |
Oral dosage formulations of protease-resistant polypeptides
|
ES2476253T3
(en)
*
|
2007-05-01 |
2014-07-14 |
Biogen Idec Ma Inc. |
Neublastin peptides for use in increasing vascularization in tissue with impaired blood flow
|
WO2009020964A2
(en)
*
|
2007-08-08 |
2009-02-12 |
Biogen Idec Ma Inc. |
Anti-neublastin antibodies and uses thereof
|
US8986696B2
(en)
*
|
2007-12-21 |
2015-03-24 |
Depuy Mitek, Inc. |
Trans-capsular administration of p38 map kinase inhibitors into orthopedic joints
|
US20090162351A1
(en)
*
|
2007-12-21 |
2009-06-25 |
Depuy Spine, Inc. |
Transdiscal administration of inhibitors of p38 MAP kinase
|
WO2009126698A2
(en)
*
|
2008-04-09 |
2009-10-15 |
Ludwig Institute For Cancer Research |
Regulation of fatty acid transporters
|
US20110172293A1
(en)
|
2008-07-08 |
2011-07-14 |
Fish Jason E |
Methods and Compositions for Modulating Angiogenesis
|
US20120190042A1
(en)
*
|
2009-01-22 |
2012-07-26 |
Reuben Gobezie |
Protein biomarkers and therapeutic targets for osteoarthritis
|
CN107970445B
(en)
|
2009-03-30 |
2021-09-07 |
阿塞勒隆制药公司 |
BMP-ALK3 antagonists and uses for promoting bone growth
|
EP2427572B1
(en)
*
|
2009-05-01 |
2013-08-28 |
Illumina, Inc. |
Sequencing methods
|
MX371080B
(en)
*
|
2009-06-23 |
2020-01-15 |
Univ California |
Enhancement of bmp retention.
|
US9409983B2
(en)
*
|
2009-07-23 |
2016-08-09 |
The Board Of Trustess Of The University Of Illinois |
Methods and compositions involving PBEF inhibitors for lung inflammation conditions and diseases
|
EP2536432B1
(en)
*
|
2010-02-19 |
2018-08-08 |
Cornell University |
Method to treat autoimmune demyelinating diseases and other autoimmune or inflammatory diseases
|
JP5616973B2
(en)
*
|
2010-02-26 |
2014-10-29 |
オステムインプラント カンパニー リミテッド |
Oligopeptides that enhance osteoblast differentiation
|
US20110218141A1
(en)
*
|
2010-03-03 |
2011-09-08 |
Hamrick Mark W |
Leptin therapy to increase muscle mass and to treat muscle wasting conditions
|
EP2569253A4
(en)
|
2010-05-14 |
2013-10-02 |
Beth Israel Hospital |
Extracorporeal devices and methods of treating complications of pregnancy
|
WO2011160062A2
(en)
*
|
2010-06-17 |
2011-12-22 |
The Usa As Represented By The Secretary, National Institutes Of Health |
Compositions and methods for treating inflammatory conditions
|
WO2012006633A1
(en)
|
2010-07-09 |
2012-01-12 |
Biogen Idec Hemophilia Inc. |
Chimeric clotting factors
|
WO2012092566A1
(en)
*
|
2010-12-30 |
2012-07-05 |
Surmodics, Inc. |
Cell attachment coatings and methods
|
WO2013012733A1
(en)
|
2011-07-15 |
2013-01-24 |
Biogen Idec Ma Inc. |
Heterodimeric fc regions, binding molecules comprising same, and methods relating thereto
|
US8507446B2
(en)
*
|
2011-08-09 |
2013-08-13 |
Mackay Memorial Hospital |
Use of PEDF-derived polypeptides for treating liver cirrhosis
|
EP2802606B1
(en)
|
2012-01-10 |
2018-04-25 |
Biogen MA Inc. |
Enhancement of transport of therapeutic molecules across the blood brain barrier
|
US9920295B2
(en)
*
|
2012-02-21 |
2018-03-20 |
The Trustees Of The University Of Pennsylvania |
Bioreactor for isolation of rare cells and methods of use
|
EP2830646B1
(en)
|
2012-03-27 |
2018-03-07 |
NGM Biopharmaceuticals, Inc. |
Compositions and methods of use for treating metabolic disorders
|
US9133440B2
(en)
*
|
2012-09-27 |
2015-09-15 |
Claresa Levetan |
Generation of new pancreatic beta cells
|
EP2950807B1
(en)
|
2013-01-30 |
2018-03-28 |
NGM Biopharmaceuticals, Inc. |
Compositions and methods of use in treating metabolic disorders
|
US9161966B2
(en)
|
2013-01-30 |
2015-10-20 |
Ngm Biopharmaceuticals, Inc. |
GDF15 mutein polypeptides
|
AR095527A1
(en)
|
2013-03-15 |
2015-10-21 |
Biogen Idec Inc |
FC-FACTOR IX POLYPEPTIDE FORMULATIONS IX
|
BR112016000546A2
(en)
|
2013-07-12 |
2017-11-21 |
Ophthotech Corp |
methods to treat or prevent eye conditions
|
BR112016011930A2
(en)
*
|
2013-12-23 |
2017-09-26 |
Alk Abello As |
Peptide Combinations And Their Uses In Dust Mite Allergy Treatment
|
MD20170020A2
(en)
*
|
2014-07-30 |
2017-07-31 |
Ngm Biopharmaceuticals, Inc. |
Compositions and methods of use for treating metabolic disorders
|
AU2015339130C1
(en)
|
2014-10-31 |
2021-03-18 |
Ngm Biopharmaceuticals, Inc. |
Compositions and methods of use for treating metabolic disorders
|
AU2016215155A1
(en)
|
2015-02-04 |
2017-08-17 |
F. Hoffmann-La Roche Ag |
Tau antisense oligomers and uses thereof
|
WO2016127000A1
(en)
|
2015-02-04 |
2016-08-11 |
Bristol-Myers Squibb Company |
Methods of selecting therapeutic molecules
|
ES2901455T3
(en)
|
2015-04-03 |
2022-03-22 |
Univ Massachusetts |
Oligonucleotide compounds for the treatment of preeclampsia and other angiogenic disorders
|
JP2019503394A
(en)
|
2016-01-31 |
2019-02-07 |
ユニバーシティ・オブ・マサチューセッツUniversity Of Massachusetts |
Branched oligonucleotide
|
JP7021099B2
(en)
|
2016-03-31 |
2022-02-18 |
エヌジーエム バイオファーマシューティカルス,インコーポレーテッド |
Bound protein and how to use it
|
EP3496758A4
(en)
|
2016-08-12 |
2020-11-11 |
University of Massachusetts |
Conjugated oligonucleotides
|
EP3833763A4
(en)
|
2018-08-10 |
2023-07-19 |
University of Massachusetts |
Modified oligonucleotides targeting snps
|
AU2022299169A1
(en)
|
2021-06-23 |
2024-02-08 |
Beth Israel Deaconess Medical Center, Inc. |
Optimized anti-flt1 oligonucleotide compounds for treatment of preeclampsia and other angiogenic disorders
|